Source: International Congress 2018 – Pulmonary hypertension: therapy
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Adão (Porto, Portugal), P. Mendes-Ferreira (Porto, Portugal), D. Santos-Ribeiro (Porto, Portugal), C. Maia-Rocha (Porto, Portugal), L. Pimentel (Porto, Portugal), C. Pinto (Porto, Portugal), E. Mulvaney (Dublin, Ireland), H. Reid (Dublin, Ireland), B. Kinsella (Dublin, Ireland), F. Potus (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), M. Rademaker (Christchurch, New Zealand), S. Provencher (Quebec, Canada), S. Bonnet (Quebec, Canada), A. Leite-Moreira (Porto, Portugal), C. Brás-Silva (Porto, Portugal). Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension. 3041

Member's Comments

No comment yet.

Related content which might interest you: How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017 Year: 2017 Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008 Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension Source: Eur Respir J, 54 (5) 1900342; 10.1183/13993003.00342-2019 Year: 2019 Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008 The heat shock protein 90 inhibitor, 17-AAG, ameliorates pulmonary arteriolar and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Macitentan in pulmonary hypertension due to left ventricular dysfunction Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017 Year: 2018 Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 1160-1166 Year: 2008